ALXO 8-K 2026-10-15

ALX ONCOLOGY HOLDINGS INC (ALXO) 8-K dated 2026-10-15 — accession 0001193125-26-422992. This URL is the filing, not the ALXO hub.

ALX ONCOLOGY HOLDINGS INC (ALXO) is a biotechnology company listed on US.

ALX ONCOLOGY HOLDINGS INC filed a 8-K on 2026-10-15. Accession 0001193125-26-422992.

Cached items: 1.01, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALXO revenue for 2022-12-31 was $0. Net income was -$123.5M. ALXO currently screens at market cap $207.2M.

Not investment advice. The ALXO SEC hub lists recent forms. The stock page is the research view.